Showing results (1-10 of 153) with videos related to
Sort By:
Pageof 16
Current Opinion in Infectious Diseases|October 13, 2006
Fc receptor and complement receptor-mediated phagocytosis in host defenceG Vidarsson, J G van de WinkelInternational Reviews of Immunology|January 1, 1997
Human IgG Fc receptorsI A Heijnen, J G van de WinkelJournal of Hematotherapy|October 1, 1995
A human Fc gamma RI/CD64 transgenic model for in vivo analysis of (bispecific) antibody therapeuticsI A Heijnen, J G Van de WinkelImmunology Today|May 1, 1993
Human IgG Fc receptor heterogeneity: molecular aspects and clinical implicationsJ G van de Winkel, P J CapelImmunology Today|September 1, 1990
Human Fc gamma receptor II: a standby receptor activated by proteolysis?W J Tax, J G van de WinkelCurrent Opinion in Chemical Biology|July 27, 2001
Human antibodies as next generation therapeuticsM A van Dijk, J G van de WinkelImmunogenetics|July 31, 1998
IgG receptor polymorphisms: risk factors for diseaseW van der Pol, J G van de WinkelJournal of Immunology (Baltimore, Md. : 1950)|September 15, 1990
Effect of protease inhibitors on human monocyte IgG Fc receptor II. Evidence that serine esterase activity is essential for Fc gamma RII-mediated bindingJ G van de Winkel, M Jansze, P J CapelNederlands Tijdschrift Voor Geneeskunde|May 1, 1998
[Immunology in clinical practice. X. IgG receptors: structure, function and immunotherapy]W L van der Pol, J G van de WinkelCancer Immunology, Immunotherapy : CII|January 22, 1998
Lysis of murine B lymphoma cells by transgenic phagocytes via a human Fc gamma RI x murine MHC class II bispecific antibodyI A Heijnen, M J Glennie, J G van de WinkelPageof 16